4 results
Primary ObjectiveTo determine whether GWP42003-P affects the pharmacokinetic (PK) profile of stiripentol (STP) or valproate (VPA).Secondary Objective(s)To assess the safety and tolerability of GWP42003-P in the presence of STP or VPA.
The reliability of the Bladderscan in the postpartum period and the prevalence of asymptomatic postpartum urinary retention.
To compare which treatment (indwelling catheter versus intermittend catheterisation) has the best clinical effect in women with symptomatic PUR.
In this pilot study we have technical/methodological questions: we want to confirm the envisioned kinetic profiles of stable isotope tracers 13C-labelled SCFA delivered by catheter in 5 subjects, and to establish the time points of plasma sampling (…